AVITA Medical, Inc. (RCEL) Other Accumulated Expenses (2019 - 2026)

AVITA Medical (RCEL) has reported Other Accumulated Expenses for 8 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses rose 79.72% year-over-year to $3.3 million; the trailing twelve-month figure through Jun 2026 stood at $3.3 million (up 79.72% YoY), and the FY2025 full-year result was $2.6 million, up 100.53% from the prior year.
• Other Accumulated Expenses grew to $3.3 million in Q2 2026 per RCEL's latest filing, from $2.6 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.3 million in Q2 2026 and bottomed at $990000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $1.7 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses tumbled 40.23% in 2024, then soared 111.45% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $990000.0 in 2022, then grew by 27.88% to $1.3 million in 2023, then grew by 4.19% to $1.3 million in 2024, then surged by 100.53% to $2.6 million in 2025, then gained by 24.95% to $3.3 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $3.3 million, $2.6 million, and $2.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.